Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Zolmitriptan Nasal Spray Versus Eletriptan in the Acute Treatment of Migraine

This study has been completed.
Sponsor:
Information provided by:
California Medical Clinic for Headache
ClinicalTrials.gov Identifier:
NCT01276977
First received: January 11, 2011
Last updated: January 13, 2011
Last verified: January 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2010
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)